Bone sarcoma mortality statistics

Deaths

Deaths from bone sarcoma, 2016, UK.

Percentage of all deaths

Percentage bone sarcoma contributes to total cancer deaths, 2016, UK

Age

Peak rate of bone sarcoma deaths, 2014-2016, UK

 

Trend over time

Change in bone sarcoma mortality rates since the early 1970s, UK

Bone sarcoma is not among the 20 most common causes of cancer death in the UK, accounting for less than 1% of all cancer deaths (2016).[1-3]

In males in the UK, bone sarcoma is the 20th most common cause of cancer death (less than 1% of all male cancer deaths). In females in the UK it is not among the 20 most common causes of cancer death (less than 1% of all female cancer deaths).

60% of bone sarcoma deaths in the UK are in males, and 40% are in females.

Bone sarcoma mortality rates (European age-standardised (AS) rates Open a glossary item ) are similar to the UK average in all the UK constituent countries.

Bone Sarcoma (C40-C41), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2016

  England Scotland Wales Northern Ireland UK
Male Deaths 179 26 9 3 217
Crude Rate 0.7 1.0 0.6 0.3 0.7
AS Rate 0.7 1.1 0.6 0.4 0.7
AS Rate - 95% LCL 0.6 0.7 0.2 -0.1 0.6
AS Rate - 95% UCL 0.8 1.5 1.0 0.9 0.8
Female Deaths 115 11 11 6 143
Crude Rate 0.4 0.4 0.7 0.6 0.4
AS Rate 0.4 0.4 0.7 0.7 0.4
AS Rate - 95% LCL 0.3 0.2 0.3 0.1 0.4
AS Rate - 95% UCL 0.5 0.6 1.1 1.2 0.5
Persons Deaths 294 37 20 9 360
Crude Rate 0.5 0.7 0.6 0.5 0.5
AS Rate 0.6 0.7 0.6 0.6 0.6
AS Rate - 95% LCL 0.5 0.5 0.3 0.2 0.5
AS Rate - 95% UCL 0.6 0.9 0.9 0.9 0.6

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

See also

Data is for UK, 2016, ICD-10 C40-C41.

Last reviewed:

Bone sarcoma mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2014-2016, on average each year almost a third (30%) of deaths were in people aged 75 and over.[1-3] This is a much lower proportion of deaths in older age groups compared with most cancers.

Age-specific mortality rates rise steadily from birth to around age 15-19 and drop until around age 40-44, then rise steadily again until around age 75-79 when the rise becomes steeper. The highest rates are in the 90+ age group for males and females.

Mortality rates are similar between males and females in most age groups. 

Bone Sarcoma (C40-C41), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2014-2016

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2014-2016, ICD-10 C40-C41.

Last reviewed:

Bone sarcoma European age-standardised (AS) Open a glossary item mortality rates for males and females combined decreased by 55% in the UK between 1971-1973 and 2014-2016.[1-3] The decrease was of a similar size in males and females.

For males, bone sarcoma AS mortality rates in the UK decreased by 58% between 1971-1973 and 2014-2016. For females, bone sarcoma AS mortality rates in the UK decreased by 55% between 1971-1973 and 2014-2016.

Over the last decade in the UK (between 2004-2006 and 2014-2016), bone sarcoma AS mortality rates for males and females combined remained stable. In males AS mortality rates remained stable, and in females rates remained stable.

Bone Sarcoma (C40-C41), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2016

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Bone sarcoma mortality rates have decreased overall in all broad age groups in males and females combined in the UK since the early 1970s.[1-3] Rates in 0-24s have decreased by 39%, in 25-49s have decreased by 30%, in 50-59s have decreased by 48%, in 60-69s have decreased by 69%, in 70-79s have decreased by 64%, and in 80+s have decreased by 55%.

Bone Sarcoma (C40-C41), European Age-Standardised Mortality Rates per 100,000 Population, By Age, UK, 1971-2016

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

See also

Data is for UK, 1971-2016, ICD-10 C40-C41.

Last reviewed:

Bone sarcoma mortality rates are projected to fall by 23% in the UK between 2014 and 2035, to 1 death per 100,000 people by 2035.[1] This includes a larger decrease for males than for females.

For males, bone sarcoma European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 40% between 2014 and 2035, to fewer than 1 death per 100,000 by 2035.[1] For females, rates are projected to fall by 3% between 2014 and 2035, to 1 death per 100,000 by 2035.[1]

Bone sarcoma (C40-C41), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

It is projected that 352 deaths from bone sarcoma (155 in males, 197 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C40-C41

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as "increase" or "decrease" if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is no evidence for an association between bone sarcoma mortality and deprivation for either males or females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are similar for both males and females living in the most deprived areas compared with the least deprived.[1]

Bone sarcoma (C40-C41), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in bone sarcoma mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C40-C41

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.5 out of 5 based on 13 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page